Kimberly Clark Corp vs Tenet Healthcare Corporation — how do they compare? Kimberly Clark Corp trades at $97.59 (market cap $32.51B), while Tenet Healthcare Corporation trades at $263.78 (market cap $20.98B). The key difference: Kimberly Clark Corp is the larger of the two by market cap, and Kimberly Clark Corp pays a 5.24% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kimberly Clark Corp for 93 Days and Tenet Healthcare Corporation for 15 Days on average.
| KMB | THC | |
|---|---|---|
Market Cap | $32.51B | $20.98B |
Volume | 6,139,913 | 428,008 |
Sector | Consumer Staples | Health |
52-Week High | $121.44 | $280.77 |
52-Week Low | $93.05 | $161.37 |
Typical Hold Time | 93 Days | 15 Days |
Enterprise Value | $38.07B | $32.06B |
Dividend Yield | 5.24% | — |
Signals from Pluang's Aura AI — not financial advice
Kimberly-Clark (KMB) trades at $97.74, up 1.31% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong profitability with 11.79% net margins and 129.43% ROE, though Q2 2026 earnings missed expectations. Recent news highlights executive transitions and the pending Kenvue acquisition, while dividend sustainability questions emerge amid cash flow pressures. Analyst consensus remains cautious with 61% hold ratings despite a $117.25 price target suggesting 20% upside.
KMB presents a value opportunity with attractive dividend yield near 5%, but faces integration risks from the Kenvue deal and cash flow challenges. The stock's current discount to analyst targets offers potential upside if execution improves, though investors should monitor dividend coverage and acquisition integration closely given the bearish technical trend and mixed earnings performance.
Tenet Healthcare (THC) trades at $260.57, showing modest daily gains of 0.28% with strong technical support at $257 and resistance at $262. The stock demonstrates robust fundamentals with a P/E of 10.07, net income margin of 9.9%, and consistent earnings beats in recent quarters. Recent news highlights the upcoming Q3 2026 earnings release on October 29, 2026, while the company maintains strong cash flow generation of $3.54 billion from operations.
THC presents a compelling investment case with 81% analyst buy ratings and a $283.36 consensus price target representing 8.7% upside potential. The company's expanding capital return strategy and projected revenue growth to $22.6 billion in 2026 support bullish sentiment, though investors should monitor surgical volume trends and capital allocation sustainability as key risks.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →